Home » Topics » Regulatory

Regulatory
RSS

European approval of Acomplia

June 23, 2006

Avastin approved for second-line use in metastatic colorectal cancer

June 21, 2006

Hycamtin approved for use with cisplatin in cervical cancer

June 19, 2006

Humira approved in Europe for ankylosing spondylitis

June 8, 2006

Betaferon approved in Europe as first-line treatment for earliest stages of MS

June 8, 2006

Zetia approved for use in combination with fenofibrate

May 30, 2006

Cubicin approved for S. aureus bloodstream infections

May 29, 2006

Zostavax approved in U.S. for prevention of shingles

May 29, 2006

Seasonique extended-cycle oral contraceptive receives FDA approval

May 29, 2006

Ganfort approved for glaucoma in E.U.

May 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 17, 2025.
Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM
BioWorld
The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as...
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.